Compagnie du Bois Sauvage SA, (also CBS), is a Belgium-based holding company that invests in both listed and unlisted companies. The Company provides assistance in financial management, structural development and capital stability to the companies in which it invests. The Company's portfolio is based on three separate pillars: a Real Estate sector, a Long-Term Investment division composed of strategic participating interests and a Cash Portfolio focused on liquid values that serve as a basis for derivatives activity. As of December 31, 2011, CBS had a number of wholly owned subsidiaries, such as Parfina, CBS Services, Neuhaus and CBS Nederland and affiliated companies, including Cofinimmo, Ceran, Codic, Noel Group, among others. In March 2014, it acquired Chocolate-Maker Corne Port Royal, sold its stake in Ceran and a real estate property in Luxembourg.

Leasinvest Real Estate is a real estate investment trust. Co. invests in retail buildings, offices and logistics buildings, in the Grand Duchy of Luxembourg and in Belgium. As of Dec 31 2013, Co.'s real estate portfolio is composed of 34 sites (including the assets held for sale & the development projects) with a total surface of 429,579 m2, of which 18 are located in Luxembourg and 16 in Belgium. Co. rents its properties to tenants across various business sectors, such as services, retail and wholesale, financial services, transport and distribution, government and non-profit, industry, medical and pharma, and ICT.

ThromboGenics is an integrated biopharmaceutical company based in Belgium. Co. is focused on developing and commercializing ophthalmic medicines. Co.'s primary product JETREA® (ocriplasmin), has been approved by the U.S. FDA for the treatment of symptomatic Vitreomacular Adhesion (VMA). In Europe, it has been approved for the treatment of vitreomacular traction (VMT), including when associated with macular hole of diameter less than or equal to 400 microns. Co. is also further exploring anti-PIGF (Placental Growth Factor), formerly referred to as TB-403, for the treatment of ophthalmic and oncology indications.

Recticel is engaged in the production of a variety of polyurethane foams that are used in the furniture, technical, automotive, bedding and insulation industries. The Flexible Foam Business Line covers the manufacture, conversion and marketing of flexible polyurethane foam. The types of flexible foams are classified as Comfort, Technical Foams and Composite Foams. Co. is also engaged in the manufacture of foams used in mattresses and slat bases. In addition, Co. manufactures rigid polyurethane and phenolic foams for thermal insulation. Co.'s automotive activities include: manufacturing moulded seat cushions, window encapsulation and manufacturing interior trim components.